Grantham, Mayo, Van Otterloo & Co (GMO)
CEL

Grantham, Mayo, Van Otterloo & Co (GMO)’s Cellcom Israel, Ltd. CEL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CEL Stock Details CEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,774
Closed -$184K – 646
2017
Q3 		$184K Sell
19,774
-26,587
-57% -$244K ﹤0.01% 540
2017
Q2 		$446K Buy
46,361
+25,032
+117% +$247K ﹤0.01% 423
2017
Q1 		$221K Buy
+21,329
New +$219K ﹤0.01% 530

Other funds holding CEL

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CEL Position: Q4 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cellcom Israel, Ltd. (CEL) in Q4 2017, closing a stake of 19,774 shares — an estimated $184K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CEL in Q1 2017 and held it in 3 quarters. The position peaked at $446K in Q2 2017. 40 funds tracked by Wall St. Rank hold CEL as of Q4 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cellcom Israel, Ltd. position as of Q4 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 19,774 Cellcom Israel, Ltd. shares in Q4 2017, an estimated $184K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cellcom Israel, Ltd. in Q1 2017 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cellcom Israel, Ltd. position peaked at $446K in Q2 2017.
  • 40 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q4 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.